Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?

A. Khan (Riyadh 11426, Saudi Arabia), R. Rajendram (Riyadh 11426, Saudi Arabia), H. Aljahdali (Riyadh 11426, Saudi Arabia), A. Harbi (Riyadh 11426, Saudi Arabia), M. Alghamdi (Riyadh 11426, Saudi Arabia), S. Alrasheed (Riyadh 11426, Saudi Arabia), M. Hamadi (Riyadh 11426, Saudi Arabia), B. Alghamdi (Riyadh 11426, Saudi Arabia), S. Alrahji (Riyadh 11426, Saudi Arabia)

Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Session: New approaches to pulmonary rehabilitation and chronic care
Session type: E-poster
Number: 2125

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Khan (Riyadh 11426, Saudi Arabia), R. Rajendram (Riyadh 11426, Saudi Arabia), H. Aljahdali (Riyadh 11426, Saudi Arabia), A. Harbi (Riyadh 11426, Saudi Arabia), M. Alghamdi (Riyadh 11426, Saudi Arabia), S. Alrasheed (Riyadh 11426, Saudi Arabia), M. Hamadi (Riyadh 11426, Saudi Arabia), B. Alghamdi (Riyadh 11426, Saudi Arabia), S. Alrahji (Riyadh 11426, Saudi Arabia). Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?. 2125

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019


The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Integrating Ambulatory Oxygen assessments into a specialist Interstitial Lung Disease (ILD) clinic
Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1
Year: 2020


Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019

What motivates primary healthcare practitioners to refer patients with Chronic Obstructive Pulmonary Disease (COPD) to Pulmonary Rehabilitation? A survey using the Theoretical Domains Framework.
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020


An assessment of nurse led follow up of pulmonary nodules
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016

Selection of patients from Pulmonary Rehabilitation (PR) to Disease Management (DM) programmes
Source: International Congress 2017 – Latest insights into the management of chronic lung diseases
Year: 2017

Changes in pulmonary function in patients with lung tuberculoma
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014

Body composition in COPD patients; benefits of segmental assessment
Source: International Congress 2014 – Latest insights in physical activity, exercise testing and muscles
Year: 2014


Evaluation of the need for an Advanced Practice Nurse for COPD patients with a pulmonary exacerbation in Switzerland
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019




Differences in pulmonary rehabilitation outcomes in patients after single or double lung transplantation
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014

The two week wait pathway: Is it used appropriately?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
Source: International Congress 2017 – Rare diseases
Year: 2017

The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014

How can we increase Pulmonary Rehabilitation (PR) uptake and outcomes in COPD patients?
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


Eligibility for Lung Volume Reduction in patients with COPD attending Pulmonary Rehabilitation
Source: Virtual Congress 2020 – Challenging issues in thoracic surgery
Year: 2020




Effect of Pulmonary Rehabilitation on Functional Exercise Capacity and Hypoxemia in Patients with Interstitial Lung Diseases: a retrospective study
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

The role of Surgical Lung Biopsy in Interstitial Lung Diseases. Is it mandatory in this time of multiple diagnostic procedures? Analysis of 186 patients surgically treated.
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019

Treatment of pulmonary carcinoid: Are there new options?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014